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Introduction {#sec1}
============

DNA methylation is a key mechanism of epigenetic control that is required for development and survival by regulating gene expression and genome stability ([@bib3]; [@bib37]). Methylation of cytosines in DNA is established by *de novo* methylases Dnmt3a and Dnmt3b, whereas its propagation after DNA replication and repair depends on the maintenance of methylase Dnmt1. In the latter process, Dnmt1 recognizes the hemimethylated DNA duplex and copies the methylation pattern of the parental strand to the newly synthesized DNA strand. Considerable information is available concerning the structure and function of the various domains of the Dnmt1 protein, providing the basis to interpret the functional consequences of structural variants ([@bib7]; [@bib38]; [@bib41]; [@bib46]). In accordance with its central cellular function ([@bib37]), mice lacking *Dnmt1* die at around day 9.5 of embryonic development ([@bib27]). Similarly, mutations of zebrafish dnmt1 predicted to impair the function of the catalytic domain die at 8 days postfertilization (dpf) ([@bib1]). This early embryonic lethality conceals a possible tissue-specific function of this protein in the adult organism.

Lymphocytes represent the cellular underpinning of the adaptive immune system and are, as all blood lineages, descendants of hematopoietic stem cells. The molecular basis of their differentiation, proliferation, selection, and maturation has been extensively studied ([@bib33]; [@bib9]; [@bib8]; [@bib29]), particularly with respect to the functional roles of certain transcription factors. By contrast, the intricacies of the epigenetic control of lymphopoiesis are only beginning to be explored. Nonetheless, previous work has indicated that DNA methylation is important for normal hematopoietic development ([@bib24]; [@bib13]; [@bib6]); for instance, low levels of Dnmt1 protein are associated with failure of normal lymphocyte development ([@bib5]) and leukemogenesis ([@bib12]). However, so far, hypomorphic germline mutations compatible with a normal life span and selective failure of lymphoid differentiation have not been described in vertebrates.

Here, using a forward genetics approach with medaka and zebrafish, we have identified missense mutations in functionally important regions of dnmt1 that result in reduced enzymatic activities. The identification of the structural consequences of these missense mutations has allowed us to generate a mouse model of a recessive and viable *Dnmt1* missense mutation that also gives rise to an enzyme of reduced activity. For the first time, these viable mutations provide a pan-organismic view of DNMT1 function in vertebrates that are separated by several million years of independent evolution. Remarkably, in all three species, DNMT1 mutations are associated with impaired lymphoid development. This demonstrates that hematopoietic precursors poised to feed the lymphoid lineages are uniquely sensitive to perturbations of the DNA methylation process. We thus conclude that an ancient epigenetic control mechanism was deployed to enable the development of lymphocytes, which represents a key innovation in the vertebrate immune system ([@bib4]).

Results {#sec2}
=======

Previously, we have conducted large-scale forward genetic screens in zebrafish ([@bib47]; [@bib23]; [@bib36]), and medaka ([@bib11]; [@bib20], [@bib21], [@bib22]) aimed at identifying mutations affecting vertebrate T cell development. As a result, several dozens of mutants exhibiting a noticeable reduction of developing T cells in the thymus in early larval development were identified. Here, we describe the first two viable recessive alleles of teleost *dnmt1*, overcoming the previous limitations on phenotypic analyses imposed by lethal *dnmt1* alleles.

A Zebrafish *dnmt1* Mutation Specifically Affecting Lymphopoiesis {#sec2.1}
-----------------------------------------------------------------

In line IY071, the extent of T cell development in the thymus at 5 days after fertilization (dpf) is severely reduced, as determined by whole mount RNA *in situ* hybridization ([@bib23]). The mutation in the IY071 line was identified as a missense mutation (T to G at nucleotide position 3:54,337,492 \[GRCz10\]) in *dnmt1* causing the substitution of the asparagine residue 1391 to lysine (N1391K) ([@bib23]) ([Figure 1](#fig1){ref-type="fig"}A). The amino acid replacement occurred in a region exhibiting an exceptional degree of evolutionary conservation ([Figure 1](#fig1){ref-type="fig"}A). In the mouse protein, this residue is equivalent to N1510 and is situated in the target recognition domain (TRD) of Dnmt1 ([@bib38]). The mutants of both sexes reached adulthood, and apart from a slight size difference ([Figure 2](#fig2){ref-type="fig"}A), fish appeared grossly normal. Adult fish exhibited impaired development of T cells ([Figure 2](#fig2){ref-type="fig"}B) and B cells ([Figure 2](#fig2){ref-type="fig"}C), as determined by RNA *in situ* hybridization and subsequent qPCR-based gene expression analyses in whole kidney marrow cells; other hematopoietic cell lineages appear to be less affected ([Figure 2](#fig2){ref-type="fig"}D). Next, we examined whether the hematopoietic environment in *dnmt1* mutants was capable of supporting normal blood cell development. To do this, we transplanted whole kidney marrow cells of wild-type *ikzf1:egfp* transgenic zebrafish into non-irradiated adult *dnmt1* mutants as recipients; the reporter transgene marks the lymphocyte lineage in zebrafish ([@bib2]; [@bib14]). When assayed at 8 days after transplantation, donor cell engraftment was detectable in the thymus (data not shown) and kidney ([Figure S1](#mmc1){ref-type="supplementary-material"}A) of 50% (7/14) of *dnmt1* mutant recipients; by contrast, donor cells were not found in wild-type and heterozygous recipients (0/16; difference significant at p = 0.002, Χ^2^-test), presumably as a consequence of MHC mismatches between donor and recipient. Collectively, these results suggest that the non-hematopoietic microenvironment of *dnmt1* mutants is capable of supporting the differentiation of wild-type lymphocytes. We attribute the failure of engraftment in some *dnmt1* mutants to the residual presence of lymphocytes, which is evident from lymphocyte-specific transcripts in kidney marrow cells ([Figure S1](#mmc1){ref-type="supplementary-material"}B); this indicates that the block of lymphocyte differentiation in the *dnmt1* zebrafish mutant is incomplete. However, it is also possible that the variable outcome of the transplantation experiments is due to different fitness levels of mutant recipient and wild-type donor progenitor cells. When kidney marrow cells of successfully reconstituted *dnmt1* mutants were secondarily transplanted into *c-myb* mutants (which lack both hematopoietic progenitor and mature blood cells and thus serve as universal recipients ([@bib16])), EGFP^+^ cells were found to be present in the kidney ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and thymus ([Figure S1](#mmc1){ref-type="supplementary-material"}D) of secondary recipients. This finding suggests that long-term reconstituting hematopoietic precursor cells survive in the *dnmt1* mutant recipients and supports the notion of the hematopoietic origin of failing lymphopoiesis in *dnmt1* mutants.Figure 1Identification of Missense Mutations in Medaka and Zebrafish *dnmt1* Genes(A) Schematic structure of the DNMT1 protein with relevant protein domains indicated; NLS, nuclear localization signal; RFTS, replication foci targeting site; CXXC, cysteine-rich domain; BAH, bromo-adjacent homology domains 1 and 2; MTase, catalytic domain. (Arrow) Approximate position of the amino acid replacement in the target recognition domain, TRD (top panel). Alignments of amino acid sequences of human (*Hs*), mouse (*Mm*), zebrafish (*Dr*), and medaka (*Ol*) dnmt1 proteins at the region close to the medaka (red, middle panel) and zebrafish (red, bottom panels) missense mutations.(B) Average methylation levels of CpGs in indicated CpG islands of total body DNA in zebrafish *dnmt1* mutants and siblings at 18 dpf. ∗p \< 0.05, ∗∗p \< 0.01; t test, two-tailed.(C) Average methylation levels of CpGs in indicated CpG islands of total body DNA in medaka *dnmt1* mutants and siblings at 18 dpf. ∗p \< 0.05, ∗∗p \< 0.01; t test, two-tailed.(D) Enzymatic activities (mol CH~3~ incorporated/h/mol of Dnmt1) of mouse wild-type and N1510K variant Dnmt1 proteins as a function of temperature T measured in Kelvin displayed as Arrhenius plots; mean ± SEM (n = 3).(E) Enzymatic activities (mol CH~3~ incorporated/h/mol of Dnmt1) of mouse wild-type and K979E variant Dnmt1 proteins as a function of temperature T measured in Kelvin displayed as Arrhenius plots; mean ± SEM (n = 3).See also [Figures S1](#mmc1){ref-type="supplementary-material"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"}.Figure 2Both T Cell and B Cell Development Are Predominantly Affected in Zebrafish Adult *dnmt1* Mutant(A) Gross appearances of *dnmt1* mutants at 18 dpf. Scale bar, 1mm (left panel). Standard lengths of *dnmt1* mutant fish at 18dpf. *dnmt1*^+/+^ (n = 7), *dnmt1*^+/m^ (n = 7), *dnmt1*^m/m^ (n = 4) (middle panel). Standard lengths of *dnmt1* mutant fish at 9 wpf. *dnmt1*^+/+^ (n = 8), *dnmt1*^+/m^ (n = 9), *dnmt1*^m/m^ (n = 7) (right panel).(B) Hematoxylin/eosin (HE) staining and RNA *in situ* hybridization using *rag1* and *foxn1* probes of paraffin sections of thymic region of *dnmt1* mutant at 9 wpf. Scale bars, 100 μm.(C) H&E staining and RNA *in situ* hybridization using *rag1* and *igm* probes of paraffin sections of kidney region of *dnmt1* mutant at 9 wpf. Scale bars, 100 μm.(D) Gene expression levels for indicated genes in whole kidney marrow samples of *dnmt1*^*+/+*^ and *dnmt1*^*m/m*^ at 18 wpf as assessed by qPCR; mean ± SEM. The values for wild-type controls are set to 1.0.See also [Figures S1](#mmc1){ref-type="supplementary-material"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"}.

A Medaka *dnmt1* Mutation Specifically Affecting Embryonic Lymphopoiesis {#sec2.2}
------------------------------------------------------------------------

The *gyokuro* (*gkr*; strain *j48-12B*) mutant line exhibited a reduction of *rag1*-expressing immature thymocytes at stage 35 (equivalent to 5 days after fertilization \[dpf\]) ([@bib19]) in whole mount RNA *in situ* hybridization assays ([@bib20]) ([Figure 3](#fig3){ref-type="fig"}A); this contrasts with normal expression of *foxn1*, a marker of thymic epithelium ([@bib35]) ([Figure 3](#fig3){ref-type="fig"}B). A combinatorial approach consisting of linkage analysis and genome sequencing ([Table S1](#mmc1){ref-type="supplementary-material"}) identified a missense mutation ([Figure 3](#fig3){ref-type="fig"}C) in the second BAH domain of dnmt1, K850E ([Figure 1](#fig1){ref-type="fig"}A). This region is well conserved in vertebrate DNMT1 enzymes; in the mouse protein, this residue is equivalent to K979E ([Figure 1](#fig1){ref-type="fig"}A). Detailed characterization of the *gkr* mutant suggested that the *dnmt1* missense mutation predominantly affects the lymphoid lineage of mutant embryos, whereas myeloid and erythroid differentiation pathways---as determined by RNA *in situ* hybridization using *mpx*- and *gata1*-specific probes---appear to be unimpaired ([Figures 3](#fig3){ref-type="fig"}D and 3E). By contrast, adult hematopoiesis was found to be essentially normal in the *gkr* mutants. This is evident from the normal cellularity of the thymus as revealed by analysis of *gkr* mutants transgenic for a *rag1:egfp* reporter ([@bib28]) ([Figure 3](#fig3){ref-type="fig"}F) and also in histological studies and RNA *in situ* hybridizations of thymus ([Figure 3](#fig3){ref-type="fig"}G) and kidney ([Figure 3](#fig3){ref-type="fig"}H) with a *rag1*-specific probe; moreover, analysis of kidney marrow cells by flow cytometry ([Figure 3](#fig3){ref-type="fig"}I) showed no abnormalities. Collectively, these results suggest that aberrations in the larval stages of T cell development are followed by an appreciable recovery of lymphopoiesis in adult medaka *dnmt1* mutants, which exhibit a normal life-span.Figure 3Impaired Lymphocyte Development in Medaka *dnmt1* Mutant(A) Whole mount RNA *in situ* hybridization pattern in *gkr* mutant using a *rag1* probe at stage 35 (5 dpf). Ventral view. Right panels display enlarged thymic areas marked in left panels. Scale bar, 200 μm.(B) Expression of the thymic epithelia cell marker *foxn1* in *dnmt1* mutant at stage 35. Right panels display enlarged thymic areas of left panels. Scale bar, 200 μm.(C) Representative sequence traces indicating the A \> G transversion at nucleotide position 8,624,154 (MEDAKA1 in Ensembl release 72) on chromosome 8. The conceptual translation in three-letter code is also shown.(D) Expression of macrophage marker *mpx* in *dnmt1* mutants at stage 22 (1.5 dpf). Scale bar, 500 μm.(E) Expression of erythroid marker *gata1* in *dnmt1* mutant at stage 25 (2 dpf). Scale bar, 500 μm.(F) Expression of *rag1:egfp* transgene in *dnmt1* mutant at 7 wpf. Scale bar, 2 mm.(G) H&E staining and RNA *in situ* hybridization using a *rag1* probe on paraffin sections of the thymic region of *dnmt1* mutant at 7 wpf. Scale bars, 100 μm.(H) H&E staining and RNA *in situ* hybridization using a *rag1* probe on paraffin sections of the kidney region of *dnmt1* mutant at 7 wpf. Scale bars, 50 μm. For (F)-(H), figures are representative of 1 fish per genotype.(I) Flow cytometric profiles of whole kidney marrow cells of *dnmt1* mutant at 7 wpf. Light scatter profiles with percentages of erythroid (red), lymphoid (light blue), myeloid (green), and precursor (purple) indicated; mean ± SEM is shown; *dnmt1*^+/+^ (n = 3), *dnmt1*^m/m^ (n = 7) (left panels). Percentages of lymphoid population, mean ± SEM is shown; *dnmt1*^+/+^ (n = 3), *dnmt1*^+/m^ (n = 7), *dnmt1*^m/m^ (n = 7) (right panel). N.S., not significant.Panels A, B, D, and E representative of at least 8 fish per genotype. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

DNA Hypomethylation in *dnmt1* Mutants {#sec2.3}
--------------------------------------

The non-conservative amino acid replacements in zebrafish and medaka *dnmt1* mutants ([Figure 1](#fig1){ref-type="fig"}A) predict reduced enzymatic activities for the altered proteins. This was examined in two ways. First, we used bisulfite sequencing using DNA extracted from the bodies of 18 dpf wild-type and mutant zebrafish and medaka fish. We focused our analysis on eight CpG islands, which were previously shown to be differentially methylated between sperm and oocyte DNA of zebrafish (five CpG islands were hypermethylated and three were hypomethylated in sperm) ([@bib32]). In zebrafish, the average methylation levels of six CpG islands were substantially lower in mutants, whereas little change was observed in two CpG islands already exhibiting low methylation levels ([Figure 1](#fig1){ref-type="fig"}B). When the eight orthologous CpG islands in the medaka genome were examined, we found that the average methylation levels of seven CpG islands were also significantly lower in medaka mutants ([Table S2](#mmc1){ref-type="supplementary-material"}; [Figure 1](#fig1){ref-type="fig"}C). These results suggest that the *dnmt1* missense mutations in zebrafish and medaka identified here affect the extent of maintenance of DNA methylation in similar ways and eventually cause hypomethylation in somatic tissues. Second, we studied the consequences of replacing the two evolutionarily conserved residues on the *in vitro* activities of the mouse Dnmt1 enzyme. To this end, we mutated the mouse *Dnmt1* gene to generate the orthologous mutants (K979E for the medaka mutation and N1510K for the zebrafish mutation); we then expressed the wild-type and the two mutant forms in a baculovirus system and used the purified proteins for *in vitro* methylation assays using a hemimethylated DNA substrate. Both mutants exhibited drastically reduced maintenance methylation activities; in addition, the K979E mutant exhibited a notable temperature sensitivity at 37°C ([Figures 1](#fig1){ref-type="fig"}D and 1E).

Structural Basis of Reduced Enzymatic Activities of Dnmt1 Mutants {#sec2.4}
-----------------------------------------------------------------

Since the recessive missense mutations in zebrafish and medaka *dnmt1* genes identified here represent the only viable vertebrate mutant *dnmt1* alleles so far described, we set out to determine the structural basis of impaired maintenance methylation. We first examined the available information on the structure of the mouse Dnmt1 protein ([@bib7]; [@bib38]; [@bib41]; [@bib46]) to locate the corresponding residues that are mutated in zebrafish and medaka dnmt1 proteins. This analysis was facilitated by the high degree of evolutionary conservation of the regions containing the two mutations ([Figure 1](#fig1){ref-type="fig"}A). Remarkably, we found that the medaka mutation in the BAH2 domain is positioned in close proximity to the zebrafish mutation in the TRD of the enzyme. In the mouse Dnmt1 protein, residues Y980 and H1511 (both situated very close to the altered residues, *i.e*., equivalent to mouse residues K979 and N1510, respectively) directly interact with each other ([Figure 4](#fig4){ref-type="fig"}A) ([@bib38]; [@bib41]). These structural features suggested a common mechanism leading to the impairment of DNMT1s enzymatic activity and prompted us to explore the structural consequences of the two mutations by molecular dynamics simulation. When the zebrafish mutation is modeled by replacing asparagine 1510 with a lysine residue, new hydrogen bonds are formed with bases of the substrate DNA near the hemimethylated site ([Figures 4](#fig4){ref-type="fig"}B and 4C); we propose that these changes interfere with the processivity of the Dnmt1 enzyme. When the structure of zebrafish dnmt1 protein is modeled on the basis of the mouse Dnmt1 crystal structure ([Figure S2](#mmc1){ref-type="supplementary-material"}A), the emergence of new hydrogen bonds between K1391 and the substrate DNA is again observed ([Figure S2](#mmc1){ref-type="supplementary-material"}B), suggesting that the model of the zebrafish protein calculated from molecular dynamics simulation is an accurate representation of its three-dimensional structure. Further simulations aimed at examining the structural consequences of the medaka mutation indicated that replacing lysine 979 with glutamic acid in mouse Dnmt1 causes a structural rearrangement that repositions Y980 next to D1438; as a result, the substrate DNA is dislodged from the catalytic cleft ([Figures 4](#fig4){ref-type="fig"}D and 4E). These structural changes are mirrored in the model of the medaka K850E mutant protein ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Collectively, the structural studies explain the hypomorphic nature of the two dnmt1 missense mutations through specific structural rearrangements of the catalytic site of the enzyme.Figure 4Structure of Wild-type and Variant Dnmt1 Proteins(A) Structure of the catalytic pocket of the mouse *Dnmt1* protein ([@bib38]), highlighting the spatial proximity of the two mutated residues; zebrafish missense mutation corresponding to mouse residue N1510 and medaka missense mutation corresponding to mouse residue K979. The hemimethylated DNA substrate is indicated in orange, with the position of the 5-methylcytosine (5mC) indicated.(B and C) Comparison of the catalytic pockets of mouse wild-type (B) and N1510K mutant (C) Dnmt1 proteins as determined by molecular dynamics simulation; note the formation of hydrogen bonds between the lysine residue and the guanine (G) base (red dotted line).(D and E) Comparison of the catalytic pockets of mouse wild-type (D) and K979E mutant (E) Dnmt1 proteins as determined by molecular dynamics simulation; note the distortion of the catalytic pocket in the mutant variant.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Embryonic Lethality of N1510K and K979E Mouse Mutants {#sec2.5}
-----------------------------------------------------

The functional and structural studies reported above implied that the introduction of the N1510K and K979E mutations into the mouse germline should cause an impaired activity of the mutant Dnmt1 proteins *in vivo*. To confirm this, we generated the appropriate nucleotide changes in the mouse *Dnmt1* gene by CRISPR/Cas9-mediated nucleotide replacement and examined the phenotype of the resulting mutant lines. Mice homozygous for either mutation exhibited embryonic lethality, similar to *Dnmt1*-deficient mice ([@bib27]). The phenotype of heterozygous mutants was found to be indistinguishable from that of wild-type siblings, indicating the recessive nature of the two mutant alleles. Based on the non-linear temperature-dependent loss of enzymatic activities of mutant proteins ([Figures 1](#fig1){ref-type="fig"}D and 1E), we propose that owing to the higher body temperature of mice (∼37°) compared with fish (∼28°C), the DNA methylase activities of both mutants fall below the threshold of activities required to sustain normal mouse development.

Structure-Guided Generation of a Viable *Dnmt1* Mutant {#sec2.6}
------------------------------------------------------

Although the orthologous zebrafish and medaka mutations in *Dnmt1* were not compatible with extended survival of homozygous mutant mice, our structural studies nevertheless provided a useful starting point to explore other mutations in Dnmt1. To this end, we focused on the H1511 residue, which was shown to be important in configuring the catalytic site of Dnmt1 ([@bib38]; [@bib41]) ([Figure 4](#fig4){ref-type="fig"}A). Here, we report on a mutation that converts histidine 1511 to aspartic acid, H1511D. The outcome of molecular dynamics simulation indicated that the H1511D mutation causes the side chain of N1510 to reposition near to the indol group of tryptophane 1512 ([Figure 5](#fig5){ref-type="fig"}A). As expected, this structural rearrangement in the catalytic center is accompanied by reduced enzymatic activity *in vitro*; the H1511D mutation reduces maintenance activity to about 50% of the wild-type version ([Figure 5](#fig5){ref-type="fig"}B). The residual activity of the H1511D mutant is higher than those observed for the N1510K and K979E mutations (about 30% and 5%, respectively) ([Figures 1](#fig1){ref-type="fig"}D and 1E); this result indicates that we achieved our goal of generating a hypomorphic version of the enzyme with intermediate level of activity. Next, we used CRSPR/Cas9 mutagenesis to introduce the H1511D mutation into the germline of mice. Mice homozygous for the H1511D mutation are viable, providing *in vivo* evidence that the phenotypic consequences of the H1511D mutation are less severe than those of the N1510K and K979E mutations. Several phenotypic features of H1511D homozygous mutant mice are notable. The animals are smaller and have a reduced body mass (2/3 of normal weight at 7 weeks of age); these findings hint at pleiotropic effects of the mutation that do, however, not compromise viability. Considering the observations made in the two teleost models, we focused on the hematopoietic system of H1511D/H1511D mice. With respect to the cellularity in lymphoid organs, we found that the number of bone marrow cells is reduced to half, whereas the numbers of thymocytes and splenocytes are reduced even further to about 40% of wild-type levels ([Figure 5](#fig5){ref-type="fig"}C). In stark contrast to the previously described model of low Dnmt1 activity ([@bib5]), the Dnmt1^H1511D/H1511D^ mice did not develop hematological malignancies. Both male and female homozygous mutants proved to be fertile, indicating that differentiation of gametes in the mutants is unimpaired. We conclude that the H1511D mutation represents a unique mouse model with which enables us to examine the physiological role of Dnmt1 in development and in adult organ function.Figure 5A Mouse Model of Impaired Dnmt1 Activity(A) Structure of the distorted catalytic pocket of the mouse H1511D Dnmt1 variant. The hemimethylated DNA substrate is indicated in orange.(B) Enzymatic activities (mol CH~3~ incorporated/h/mol of Dnmt1) of mouse wild-type and H1511D variant Dnmt1 proteins as a function of temperature in degree Celsius.(C) Phenotypic features of H1511D homozygous mutant in 6-week-old mice. Body weight (left panel); absolute cell numbers of bone marrow, thymus, and spleen.(D) Absolute cell numbers of HSC and MPP precursor populations in bone marrow.(E) Absolute cell numbers of CLP, CMP, GMP, and MEP precursor populations in bone marrow. Note the dramatic loss of the common lymphoid progenitor (CLP).(C--E) Wild-type (blue data points) and *Dnmt1*-mutant (red data points). See also [Figures S4](#mmc1){ref-type="supplementary-material"}, [5](#fig5){ref-type="fig"}, and [7](#fig7){ref-type="fig"}.

Hematopoietic Abnormalities in Dnmt1^H1511D^ Mutant Mice {#sec2.7}
--------------------------------------------------------

Among the individual subsets of hematopoietic precursors in the bone marrow ([Figures S4](#mmc1){ref-type="supplementary-material"}A, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B), we noted several-fold reductions in the numbers of HSC, MPP1, and MPP4 subsets but little change of MPP2 and MPP3 fractions ([Figure 5](#fig5){ref-type="fig"}D); interestingly, whereas near-normal numbers of CMP, GMP, and MEP precursors were found, CLPs were reduced about 100-fold ([Figures 5](#fig5){ref-type="fig"}E and [S5](#mmc1){ref-type="supplementary-material"}A). Collectively, these findings indicate that the H1511D mutation predominantly affects the differentiation of the lymphoid lineage, reminiscent of the observations in the medaka and zebrafish mutants.

In order to examine the cell-intrinsic nature of the hematopoietic abnormalities in Dnmt1^H1511D^ mutant mice, we carried out competitive bone marrow transplantation experiments. Bone marrow cells of wild-type and *Dnmt1*-mutant cells calibrated to contain 100 HSCs each were mixed and transplanted into irradiated wild-type recipients and their hematopoietic compartment analyzed after 12 weeks. The results indicated a poor contribution of mutant cells to the reconstituted hematopoietic compartment of the host animals. In the bone marrow of reconstituted mice, we found that wild-type cells outnumbered mutant cells by three orders of magnitude; prepro-B cells, pro-B cells, and pre-B cells were particularly affected ([Figure 6](#fig6){ref-type="fig"}A), in line with the differential reductions seen in the marrow of the mutant donors ([Figures S4](#mmc1){ref-type="supplementary-material"}A and [S5](#mmc1){ref-type="supplementary-material"}B). In the thymus of reconstituted mice, CD4/CD8 double-positive (DP) cells were almost entirely of wild-type origin, whereas DN1 thymocytes ([Figure 6](#fig6){ref-type="fig"}D) and mature CD4^+^ and CD8^+^ single-positive (SP) cells ([Figure 6](#fig6){ref-type="fig"}B) exhibited greater competitive potential; again, this outcome is reminiscent of the situation of the thymus in mutant donors ([Figure S5](#mmc1){ref-type="supplementary-material"}C). In the spleen of reconstituted mice, the particular sensitivity of the B cell lineage to the H1511D mutation was readily detectable; of note, mutant CD4^+^ cells were less competitive than CD8^+^ cells ([Figure 6](#fig6){ref-type="fig"}C). In splenocytes of mutant donors, lymphocyte subsets are reduced to equal extent ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Interestingly, the contribution of mutant granulocytes and neutrophils to the reconstituted peripheral compartment was also small ([Figure 6](#fig6){ref-type="fig"}C); this suggests that although the lymphoid lineage is particularly sensitive to the effects of the H1511D mutation, the hematopoietic aberrations are not entirely lymphoid specific. Indeed, in secondary transplantation experiments no mutant cell engraftment was detectable (data not shown), suggesting that the H1511D mutation has detrimental effects also on the maintenance and/or the fitness of HSCs, at least when subjected to the transplantation procedure and/or when they are under competitive pressure *in vivo*.Figure 6Impaired Fitness of Hematopoietic Precursor Populations of H1511D Homozygous MiceThe outcome of competitive transfer of allotype-tagged precursor populations was examined after 12 weeks. Results for wild-type donor cells are shown in black symbols and those for H1511D mutant hematopoietic cells in red symbols.(A) Numbers of different cell types in the bone marrow.(B) Numbers of different cell types in the thymus.(C) Numbers of different cell types in the spleen.See also [Figures S4](#mmc1){ref-type="supplementary-material"}, [5](#fig5){ref-type="fig"}, and [7](#fig7){ref-type="fig"}.

Next, we examined the methylation status of hematopoietic precursor cells. Given the pervasive effects of the H1511D mutation, we compared the extent of methylation in Lin^--^ cells of the bone marrow. Significantly reduced methylation levels of CpG dinculeotides were detected ([Figure 7](#fig7){ref-type="fig"}A), clustered within 38,000 differentially methylated regions (DMRs), spread across the entire genome ([Table S3](#mmc2){ref-type="supplementary-material"}). We then determined gene expression profiles of HSCs, and the MPP1 and MPP4 precursor populations between wild-type and Dnmt1^H1511D^ mutant mice by RNA_seq ([Table S4](#mmc1){ref-type="supplementary-material"}). The data indicated surprisingly few significant changes of generally modest degree; however, overexpression of *Fos* and *FosB* genes was consistently found in mutant progenitor subsets ([Figure 7](#fig7){ref-type="fig"}B; [Table S4](#mmc1){ref-type="supplementary-material"}). The higher expression levels of these two genes were associated with hypomethylation of several locus-associated DMRs in Lin^--^ cells ([Figures 7](#fig7){ref-type="fig"}C, [S6](#mmc1){ref-type="supplementary-material"}A and S6B). The DMRs in the *Fos* and *Fosb* genes coincide neither with active chromatin marks nor with signatures of open chromatin that are found in HSCs, MPPs, and CLP, respectively ([@bib39]; [@bib26]; [@bib45]) (see [Figure S6](#mmc1){ref-type="supplementary-material"} for H3K4me1), indicating a complex relationship between hypomethylation and overexpression of these genes in mutant progenitor cells. Overexpression of *Fos* is known to selectively induce apoptosis in B cell precursors ([@bib18]; [@bib17]); in the H1511D mutant, we found that pre-B cells of mutant mice exhibit moderately increased death rates ([Figure 7](#fig7){ref-type="fig"}D). This effect may contribute to reduced B cell numbers, because Lin^--^ cells in the bone marrow proliferate normally ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). By contrast, overexpression of *Fos* was shown to have no effect on T cell differentiation ([@bib34]; [@bib10]); indeed, despite higher expression levels of *Fos* and *Fosb* in thymocytes ([Figure 7](#fig7){ref-type="fig"}C), no changes in proliferation ([Figure S7](#mmc1){ref-type="supplementary-material"}D) and levels of apoptosis were observed ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Collectively, these findings suggest that the drastic reduction of CLPs is the main reason for the severe cytopenia in the downstream lymphocyte differentiation pathways in mutant mice; in addition, the detrimental effect of the mutation in the B cell lineage is magnified by increased B cell apoptosis.Figure 7Characterization of the Hematopoietic Compartment of H1511D Mutant Mice(A) Extent of methylation in DMRs in lineage-negative bone marrow precursor cells.(B) Expression levels of *Fos* and *Fosb* genes in hematopoietic precursor populations of H1511D mutants relative to controls.(C) Mean methylation ratios of gene-associated DMRs in Lin^--^ bone marrow cells of the indicated genotypes. The numbers refer to the map positions in [Figure S6](#mmc1){ref-type="supplementary-material"}.(D) Elevated levels of apoptosis in pro-B cells of *Dnmt1*-mutant animals. Flow cytometric analysis (top panels); AnnexinV^+^/PI^−^ cells are in early apoptosis, whereas AnnexinV^+^/PI^+^ cells are in late stages of apoptosis. Quantification of results (bottom panels); wild-type (blue data points) and *Dnmt1*-mutant (red data points).See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

After cell division, multiple mechanisms ensure the faithful transfer of epigenetic information from the parental to the daughter cell. The DNA maintenance methylase, DNMT1, reestablishes the pattern of cytosine methylation on the newly synthesized strand after DNA replication and repair synthesis ([@bib3]; [@bib37]). Hence, loss of DNMT1 leads to epigenetic aberrations culminating in cellular lethality. From an experimental perspective, the absolute requirement of DNMT1 for cell viability hampers studies on the role of DNA maintenance methylation during development and cell differentiation and thus precludes an assessment of tissue function in adults. This is well illustrated by the early lethality associated with deletion of DNMT1 in mice ([@bib27]) and apparent null alleles of *dnmt1* in zebrafish ([@bib1]). In the latter case, maternal contributions of the enzyme to the developing embryo and larva can buffer the lack of zygotic activity only up to a certain developmental stage, highlighting the continuous requirement of (at least some level of) enzyme activity for development and differentiation. Harnessing the power of forward genetic screens, we identified two viable hypomorphic recessive alleles of DNMT1 in teleost fish. Orthologous amino acid replacements at the two critical positions in the catalytic site of mouse Dnmt1 protein conferred temperature sensitivity to the enzyme *in vitro*; this observation suggests an explanation for why the corresponding mouse alleles exhibited embryonic lethality. However, because these studies had identified the physiologically relevant region in the catalytic pocket, it became possible by structure-guided mutation of the adjacent histidine residue to generate a novel mouse *Dnmt1* allele (H1511D) with properties amenable to organismic studies. In humans, dominant missense mutations in *DNMT1* result in premature protein degradation and are associated with neuronal disorders ([@bib25]; [@bib43]; [@bib40]). Our zebrafish mutant exhibits mild haploinsufficiency with respect to body mass, but this effect is not seen in the Dnmt1^+/H1511D^ mice; moreover, no gross behavioral abnormalities were detectable in our mutant animals. In mice, low levels of wild-type Dnmt1 protein are also associated with defects in lymphoid differentiation ([@bib5]), a phenotype that partially overlaps with the one observed here. However, an important distinction is the fact that the low levels of Dnmt1 lead to leukemic transformation and death at 12 weeks of age ([@bib5]; [@bib12]). Neither in our zebrafish and medaka mutants nor in the H1511D mutant mice, leukemia development has yet been detected. This feature represents an important distinction to the previous model, because it enables the analysis of hematopoietic abnormalities without the complication of concomitant malignant transformation. Collectively, the outcomes observed with the different *DNMT1* alleles support the notion of a complex genotype-phenotype relationship, encouraging further site-specific mutagenesis studies.

The identification of viable alleles in two fish species, and the subsequent structure-guided development of a viable mouse allele, allowed us to examine the physiological consequences of impaired DNA methylation during the development of species that are separated by several hundred million years of independent evolution. It is remarkable that, among the myriad cellular differentiation events underlying the development and reproduction of the vertebrate body, and the many evolutionary innovations in organismal physiology distinguishing fish and mammals, lymphoid differentiation appears to be a common target of aberrations in DNA methylation. Although this general conclusion is well supported by our present study, there are certain notable differences among the three species. For instance, with respect to adult lymphopoiesis, we find that the phenotype in zebrafish is more severe than that in medaka; however, at present, we cannot distinguish between different degrees of functional impairment of the enzyme and divergent biological features of the two species. Nonetheless, inter-individual differences in the severity of lymphopenia in adult zebrafish are a sign of (albeit insufficient) recovery of lymphopoiesis, reminiscent of the more complete restoration in medaka mutants. It is known that larval and adult phases of zebrafish T cell development are genetically separable ([@bib36]; [@bib14]; [@bib42]); hence, it is possible that adult lymphoid progenitors undergo at least partial restoration of aberrant DNA methylation patterns. In some cases, this recovery process may be sufficient to rescue a certain degree of adult lymphopoiesis. On the other hand, the compensatory process often fails, such that a considerable fraction of mutant zebrafish accepts allogeneic transplants without the requirement of prior conditioning. Hence, from a practical perspective, the *dnmt1* mutants can be added to the growing list of immunodeficient fish lines, such as those carrying mutations in *c-myb*, *rag2*, *prkdc*, and *zap70* ([@bib15]: [@bib16]; [@bib30]; [@bib31]) that have been used for transplantation experiments in diverse settings ([@bib44]). Mice homozygous for the H1511D mutation are phenotypically more similar to zebrafish than to medaka, as indicated by the reduced lymphoid progenitor cells in the bone marrow and the thymus and the sustained peripheral cytopenia. Although our mutants are viable and grossly normal except for a smaller body size, it is well possible that they exhibit subtle abnormalities other than those of the hematopoietic system studied here; however, whatever their nature may be, they do not interfere with viability and fertility.

With respect to the molecular mechanism underlying the pathology in *dnmt1* mutants, we propose that subtle changes in the interaction of the DNMT1 enzyme with its hemimethylated target sites underlie the observed reduced levels of DNA cytosine methylation, as implied by the crystal structure of the mouse DNMT1 protein ([@bib38]; [@bib41]) and the molecular dynamics simulations reported herein. It is conceivable that the alterations in the catalytic site observed in the mutants change the mode and/or the efficiency with which the enzyme engages certain CpG dinucleotides. One obvious confounding factor is the sequence context of the CpG dinucleotide; other variables include chromatin context and altered interactions with accessory proteins in the methylase complex. Additional contributions to the altered methylation pattern could arise from compensatory *de novo* methylation processes. The structure-function relationships reported here should guide the generation of further mutants that may exhibit a different phenotypic spectrum than those uncovered in the present study.

In conclusion, our study establishes a set of three animal models with which to examine the physiological consequences of impaired maintenance methylation throughout life. The opportunity to study this in the organismal context is unprecedented and should therefore be applicable to many biological questions. Indeed, although we have focused here on hematological features of the mutant phenotype, in-depth analyses of other organ systems and physiological responses may reveal other so far undetected abnormalities. When viewed from an evolutionary angle, our study suggests that DNA methylation is required to protect the development of lymphocytes within the hematopoietic system of teleosts and mammals, which have independently evolved for several hundred millions years. Hence, it appears that an ancient epigenetic mechanism was repurposed to enable the establishment of an evolutionarily new cell type in vertebrates, underlying their adaptive immune systems.

Limitations of the Study {#sec3.1}
------------------------

Our work demonstrates that the lymphoid lineage is consistently affected in three animal models homozygous for hypomorphic mutations in *DNMT1*. However, although viability is not compromised, the mutation also affects other organ systems, such as growth rate etc. Further studies are required to examine these additional features of the phenotypes. With respect to the mouse model described here, hematopoietic precursors should be examined in more detail, in particular with respect to possible signs of haploinsufficiency. Moreover, it will be important to determine whether the consistent upregulation of *Fos* and *FosB* genes is causal for the observed lymphoid defects or whether it is an indirect consequence of DNA hypomethylation in this lineage.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Thomas Boehm (<boehm@ie-freiburg.mpg.de>).

### Materials Availability {#sec3.2.2}

All unique reagents generated in this study are available from the lead Contact with a completed Materials Transfer Agreement.

### Data and Code Availability {#sec3.2.3}

The R code necessary to reproduce statistical analyses and results presented here is reported in Supplemental Code available at <https://github.com/katsikora/Iwanami2019_SupplementaryCodeAndData_B>. The methylation and RNA_seq data have been deposited in the GEO database under accession number [GSE98648](ncbi-geo:GSE98648){#intref0020}.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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